BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stephens C, Lucena MI, Andrade RJ. Genetic risk factors in the development of idiosyncratic drug-induced liver injury. Expert Opinion on Drug Metabolism & Toxicology 2021;17:153-69. [DOI: 10.1080/17425255.2021.1854726] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Beier JI, Arteel GE. Environmental exposure as a risk-modifying factor in liver diseases: Knowns and unknowns. Acta Pharmaceutica Sinica B 2021;11:3768-78. [DOI: 10.1016/j.apsb.2021.09.005] [Reference Citation Analysis]
2 Caballano-infantes E, García-garcía A, Lopez-gomez C, Cueto A, Robles-diaz M, Ortega-alonso A, Martín-reyes F, Alvarez-alvarez I, Arranz-salas I, Ruiz-cabello F, Lucena IM, García-fuentes E, Andrade RJ, García-cortes M. Differential iNKT and T Cells Activation in Non-Alcoholic Fatty Liver Disease and Drug-Induced Liver Injury. Biomedicines 2022;10:55. [DOI: 10.3390/biomedicines10010055] [Reference Citation Analysis]
3 Huang YS, Wu CY, Chang TT, Peng CY, Lo GH, Hsu CW, Hu CT, Huang YH. Drug-induced liver injury associated with severe cutaneous adverse drug reactions: A nationwide study in Taiwan. Liver Int 2021. [PMID: 34153177 DOI: 10.1111/liv.14990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]